[ PHIC PHILHEALTH CIRCULAR NO. 08, S. 2004, January 30, 2004 ]
EXTENSION OF COMPENSABILITY OF MELOXICAM IN THE PHILHEALTH LIST OF REIMBURSABLE DRUGS (POSITIVE LIST)
As we await for the release of the official list of Section 2.0 Drugs acting on the muskoloskeletal system and joints of Vol. 1 6th edition of the Philippine National Drug Formulary (PNDF), we are extending the compensability of the drug meloxicam 7.5 mg tablet and 15 mg tablet until March 31, 2004. Meloxicam was included in the PhilHealth Positive List by virtue of PhilHealth Circular Nos. 02, s. 2003 and 30, s. 2003. Claims for this drug shall be reimbursed only when used for rheumatoid arthritis, acute lumbago and/or osteoarthritis.
This circular shall take effect on February 1, 2004, and shall apply only to all claims with admission dates starting February 1, 2004 to March 31, 2004.
All other provisions consistent with this circular remain in full force and effect.
Adopted: 30 Jan. 2004
(SGD.) FRANCISCO T. DUQUE, MD. MSc
President and CEO
This circular shall take effect on February 1, 2004, and shall apply only to all claims with admission dates starting February 1, 2004 to March 31, 2004.
All other provisions consistent with this circular remain in full force and effect.
Adopted: 30 Jan. 2004
President and CEO